Lantheus Holdings Inc (LNTH)
63.49
+1.15
(+1.84%)
USD |
NASDAQ |
Apr 19, 13:07
Lantheus Holdings Max Drawdown (5Y): 68.52% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 68.52% |
| February 29, 2024 | 68.52% |
| January 31, 2024 | 68.52% |
| December 31, 2023 | 68.52% |
| November 30, 2023 | 68.52% |
| October 31, 2023 | 68.52% |
| September 30, 2023 | 68.52% |
| August 31, 2023 | 68.52% |
| July 31, 2023 | 68.52% |
| June 30, 2023 | 68.52% |
| May 31, 2023 | 68.52% |
| April 30, 2023 | 68.52% |
| March 31, 2023 | 68.52% |
| February 28, 2023 | 68.52% |
| January 31, 2023 | 68.52% |
| December 31, 2022 | 68.52% |
| November 30, 2022 | 68.52% |
| October 31, 2022 | 68.52% |
| September 30, 2022 | 68.52% |
| August 31, 2022 | 68.52% |
| July 31, 2022 | 68.52% |
| June 30, 2022 | 68.52% |
| May 31, 2022 | 68.52% |
| April 30, 2022 | 68.52% |
| March 31, 2022 | 68.52% |
| Date | Value |
|---|---|
| February 28, 2022 | 68.52% |
| January 31, 2022 | 68.52% |
| December 31, 2021 | 68.52% |
| November 30, 2021 | 68.52% |
| October 31, 2021 | 68.52% |
| September 30, 2021 | 68.52% |
| August 31, 2021 | 68.52% |
| July 31, 2021 | 68.52% |
| June 30, 2021 | 68.52% |
| May 31, 2021 | 68.52% |
| April 30, 2021 | 68.52% |
| March 31, 2021 | 74.18% |
| February 28, 2021 | 77.34% |
| January 31, 2021 | 78.39% |
| December 31, 2020 | 78.39% |
| November 30, 2020 | 78.62% |
| October 31, 2020 | 78.62% |
| September 30, 2020 | 78.62% |
| August 31, 2020 | 78.62% |
| July 31, 2020 | 78.62% |
| June 30, 2020 | 78.62% |
| May 31, 2020 | 78.62% |
| April 30, 2020 | 78.62% |
| March 31, 2020 | 78.62% |
| February 29, 2020 | 78.62% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
68.52%
Minimum
Apr 2021
78.62%
Maximum
Apr 2019
72.46%
Average
68.52%
Median
Apr 2021
Max Drawdown (5Y) Benchmarks
| Perspective Therapeutics Inc | 91.70% |
| Eli Lilly and Co | 22.48% |
| Boston Scientific Corp | 43.49% |
| NeuroMetrix Inc | 99.78% |
| Stryker Corp | 43.80% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 11.54 |
| Beta (5Y) | 0.5349 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.56% |
| Historical Sharpe Ratio (5Y) | 0.311 |
| Historical Sortino (5Y) | 0.7199 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.61% |